August 2014 Life Science Industry Research Reports

GlobalData has released its new PharmaPoint Drug Evaluation report, “Breo Ellipta(Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

GlobalData has released its new PharmaPoint Drug Evaluation report, “Flovent (Asthma) – Forecast and Market Analysis to 20233”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

GlobalData has released its new PharmaPoint Drug Evaluation report, “Fostair (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

GlobalData has released its new PharmaPoint Drug Evaluation report, “Lebrikizumab (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

GlobalData has released its new PharmaPoint Drug Evaluation report, “Symbicort (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

GlobalData has released its new PharmaPoint Drug Evaluation report, “Bosatria (Mepolizumab) (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, […]

GlobalData has released its new PharmaPoint Drug Evaluation report, “Singulair (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

GlobalData has released its new PharmaPoint Drug Evaluation report, “Benralizumab (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

GlobalData has released its new PharmaPoint Drug Evaluation report, “Xolair (Asthma) – Forecast and Market Analysis to 2023”. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such […]

Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard […]